Study on the mechanism of naringin in promoting bone differentiation: In vitro and in vivo study

被引:3
|
作者
Li, Xian [1 ]
Zhou, Xiaojun [2 ,3 ]
Chen, Kexiao [2 ]
Jiang, Xinrong [2 ]
Lai, Renfa [1 ]
Li, Zejian [1 ,2 ,4 ]
机构
[1] Jinan Univ, Hosp Stomatol, Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Jinan Univ, Sch Stomatol, Guangzhou, Peoples R China
[3] Jinan Univ, Dept Stomatol, Affiliated Hosp 6, Dongguan, Peoples R China
[4] Jinan Univ, 601 West Huangpu Ave, Guangzhou, Guangdong, Peoples R China
关键词
Naringin; BMSCs; Osteoporotic; Osteogenesis; BMP2; POSTMENOPAUSAL WOMEN; MINERAL DENSITY; ECONOMIC BURDEN; OSTEOPOROSIS; ESTROGEN; PERIODONTITIS; ASSOCIATION; RECEPTORS; ALPHA; CELLS;
D O I
10.1016/j.heliyon.2024.e24906
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Osteoporosis is a common clinical bone disease that occurs most frequently in middleaged and elderly people. Various traditional herbal medicine formulations have shown significant benefits in models of osteoporosis. In this study, we aim to investigate the osteogenic efficacy of naringin (NRG) in the osteoporotic state. Design: We treated Bone marrow stromal cells (BMSCs) with various concentrations of NRG for 3 and 7 days. BMSC proliferation was measured by the MTT assay. The effect of NRG on the osteogenic differentiation of BMSCs was detected by ALP and alizarin red staining. The effect of NRG on the BMP2/Runx2/Osterix signaling pathway was analyzed by using real-time PCR. The effect of NRG on the oestrogen receptor was measured by Enzyme-linked immunosorbent assay. In vivo animal experiments were performed by micro-computed tomography and ALP immunohistochemistry to determine the ectopic osteogenic effect of NRG sustained-release nanoparticles in a mouse model of osteoporosis. Results: NRG promoted the proliferation and osteogenic differentiation of BMSCs. Moreover, it also activated the BMP2/Runx2/Osterix signaling pathway. When NRG sustained-release nanoparticles were added in vivo in animal experiments, we found that NRG sustained-release nanoparticles had better ectopic osteogenic effects in a mouse model of osteoporosis. Conclusions: NRG induced osteoblastic differentiation of BMSCs by activating the BMP2/Runx2/ Osterix signaling pathway and promoted the regulation of oestrogen receptor pathway protein expression, and NRG sustained-release nanoparticles exerted a more significant in vivo ectopic osteogenic effect in an osteoporosis mouse model. Therefore, naringin is expected to be developed as a novel treatment for inducing osteogenesis, because of its ubiquitous, cost-efficient, and biologically active characteristics. However, further research is needed on how to improve the pharmacokinetic properties of naringin and its specific mechanism.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Ginsenoside Rc Promotes Bone Formation in Ovariectomy-Induced Osteoporosis In Vivo and Osteogenic Differentiation In Vitro
    Yang, Nan
    Zhang, Xiao
    Li, Lingfeng
    Xu, Tongtong
    Li, Meihui
    Zhao, Qi
    Yu, Jinling
    Wang, Jue
    Liu, Zhihui
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [32] Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo
    Yonezawa, Takayuki
    Hasegawa, Shin-ichi
    Asai, Midori
    Ninomiya, Tadashi
    Sasaki, Toshinori
    Cha, Byung-Yoon
    Teruya, Toshiaki
    Ozawa, Hidehiro
    Yagasaki, Kazumi
    Nagai, Kazuo
    Woo, Je-Tae
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 650 (2-3) : 511 - 518
  • [33] Bergapten promotes bone marrow stromal cell differentiation into osteoblasts in vitro and in vivo
    Ji-jie Xiao
    Wen-ji Zhao
    Xin-tao Zhang
    Wen-long Zhao
    Xiao-xia Wang
    Shu-hui Yin
    Fang Jiang
    Yin-xia Zhao
    Fang-ni Chen
    Shao-lin Li
    Molecular and Cellular Biochemistry, 2015, 409 : 113 - 122
  • [34] Naringin and temozolomide combination suppressed the growth of glioblastoma cells by promoting cell apoptosis: network pharmacology, in-vitro assays and metabolomics based study
    Bisht, Priya
    Prasad, Surendra Rajit
    Choudhary, Khushboo
    Pandey, Ruchi
    Aishwarya, Dande
    Aravind, Vulli
    Ramalingam, Peraman
    Velayutham, Ravichandiran
    Kumar, Nitesh
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] The Effect of Naringin on the Apoptosis of Degenerative Nucleus Pulposus Cells: A Study on the Function and Mechanism
    Yuan, Zhenzhen
    Yang, Zhao
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 499 - 508
  • [36] Methotrexate chemotherapy-induced damages in bone marrow sinusoids: An in vivo and in vitro study
    Hassanshahi, Mohamamdhossein
    Su, Yu-Wen
    Fan, Chia-Ming
    Khabbazi, Samira
    Hassanshahi, Alireza
    Xian, Cory J.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 3220 - 3231
  • [37] Suppressive Effects of the Leaf of Terminalia catappa L. on Osteoclast Differentiation In Vitro and Bone Weight Loss In Vivo
    Koyama, Tomoyuki
    Nakajima, Chie
    Nishimoto, Sogo
    Takami, Masamichi
    Woo, Je-Tae
    Yazawa, Kazunaga
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2012, 58 (02) : 129 - 135
  • [38] Protective Effects of Growth Differentiation Factor-6 on the Intervertebral Disc: An In Vitro and In Vivo Study
    Miyazaki, Kunihiko
    Miyazaki, Shingo
    Yurube, Takashi
    Takeoka, Yoshiki
    Kanda, Yutaro
    Zhang, Zhongying
    Kakiuchi, Yuji
    Tsujimoto, Ryu
    Ohnishi, Hiroki
    Matsuo, Tomoya
    Ryu, Masao
    Kuroda, Ryosuke
    Kakutani, Kenichiro
    CELLS, 2022, 11 (07)
  • [39] Effects of hypoxia on proliferation and osteogenic differentiation of periodontal ligament stem cells: an in vitro and in vivo study
    Zhang, Q. B.
    Zhang, Z. Q.
    Fang, S. L.
    Liu, Y. R.
    Jiang, G.
    Li, K. F.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (04): : 10204 - 10214
  • [40] Study on the In Vitro and In Vivo Antioxidant Activity and Potential Mechanism of Polygonum viviparum L.
    Yang, Zhen
    Man, Jingyuan
    Liu, Haoyu
    Wu, Di
    Gu, Qiangwen
    Zhang, Hongjuan
    Liu, Yu
    Shao, Dan
    Hao, Baocheng
    Wang, Shengyi
    ANTIOXIDANTS, 2025, 14 (01)